Basilea Pharmaceutica AG (LON:0QNA)

Basilea Pharmaceutica AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	120.71	59.93	84.66	53.7	60.75
Short-Term Investments	-	-	-	95	101.02
Cash & Short-Term Investments	120.71	59.93	84.66	148.7	161.77
Cash Growth	101.41%	-29.21%	-43.07%	-8.08%	25.38%
Accounts Receivable	8.88	27.89	33.15	24.95	8.71
Other Receivables	49.31	30.26	28.55	39.5	23.68
Receivables	58.18	58.15	61.7	64.45	32.39
Inventory	31.61	26.41	24.24	22.78	21.19
Restricted Cash	3.85	4.39	1.91	1.25	5.51
Other Current Assets	6.56	3.27	2.85	3.88	2.66
Total Current Assets	220.91	152.15	175.36	241.07	223.53
Property, Plant & Equipment	18.98	20.55	21.57	2.92	5.28
Other Intangible Assets	0.37	0.55	0.58	0.63	0.67
Long-Term Deferred Tax Assets	17.33	-	-	-	-
Other Long-Term Assets	0.17	0.04	22.07	0.26	0.32
Total Assets	257.76	173.29	220.85	247.27	229.79
Accounts Payable	11.49	5.85	0.19	10.62	13.15
Accrued Expenses	21.5	13.1	18.9	27.9	21.3
Current Portion of Long-Term Debt	-	15.45	37.47	123.51	-
Current Portion of Leases	2.06	2.06	1.99	0.9	1.75
Current Income Taxes Payable	-	-	-	0.5	0.8
Current Unearned Revenue	1.62	1.23	1.23	1.23	2.56
Other Current Liabilities	8.89	9.9	15.07	9.76	10.6
Total Current Liabilities	45.56	47.59	74.85	174.41	50.16
Long-Term Debt	95.91	95.46	131.36	94.54	239.67
Long-Term Leases	13.7	15.64	16.32	0.01	0.9
Long-Term Unearned Revenue	11.39	9.46	10.69	11.93	13.16
Other Long-Term Liabilities	-	0	-0	-	0.16
Total Liabilities	176.77	183.29	241.56	305.87	331.84
Common Stock	13.17	13.1	13.09	12.99	11.92
Additional Paid-In Capital	1,048	1,042	1,037	1,030	982.44
Retained Earnings	-923.29	-1,001	-1,011	-1,023	-1,016
Treasury Stock	-51.7	-54.01	-56.07	-56.56	-52.77
Comprehensive Income & Other	-4.74	-10.21	-3.79	-21.62	-27.25
Shareholders' Equity	81	-10	-20.72	-58.61	-102.05
Total Liabilities & Equity	257.76	173.29	220.85	247.27	229.79
Total Debt	111.67	128.61	187.14	218.96	242.32
Net Cash (Debt)	9.04	-68.67	-102.48	-70.26	-80.54
Net Cash Per Share	0.65	-5.66	-8.58	-6.01	-7.83
Filing Date Shares Outstanding	12.13	12	11.95	11.84	10.87
Total Common Shares Outstanding	12.13	12	11.95	11.84	10.87
Working Capital	175.35	104.55	100.51	66.66	173.37
Book Value Per Share	6.68	-0.83	-1.73	-4.95	-9.39
Tangible Book Value	80.63	-10.55	-21.29	-59.24	-102.72
Tangible Book Value Per Share	6.65	-0.88	-1.78	-5.00	-9.45
Land	-	-	-	-	0.2
Buildings	-	-	-	-	1.9
Machinery	13.61	12.86	12.98	16.62	24.63
Leasehold Improvements	1.8	1.8	1.8	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.